155 results about "Allergic symptoms" patented technology

The invention relates to an anti-sensitive relieving skin-care product composition and a preparation method thereof. The skin-care product composition comprises the following raw materials by weight percent: 1-5% of an anti-irritating component, 1-3% of plant extract, 0.5-1% of a skin barrier repair agent, 0.5-1% of a wetting agent, 0.1-5% of a functional auxiliary agent and the balance of water, wherein the anti-irritating component is alpha-bisabolol, ginger root extract and hydroxymethyl chitosan oligosaccharide; and the plant extract is prepared from one or more of centella, fructus perillae, divaricate saposhnikovia root, flos magnolia and scutellaria baicalensis as raw materials. The skin-care product composition can effectively alleviate symptoms such as fever, rubedo and pruritus of skin with allergic symptoms and avoid edema, bleeding, fester and the like as the skin is scratched.

The invention discloses gel for bleaching and whitening teeth, which comprises two parts, namely whitening gel and catalyzing gel, wherein the mixture ratios of the whitening gel and the catalyzing gel are respectively that: the whitening gel consists of the following raw materials in percentage by weight: 5 to 40 percent of peroxide, 10 to 80 percent of humectant, 0.5 to 3.0 percent of adhesive, 1.0 to 10.0 percent of stabilizing agent, 1.0 to 10 percent of anti-allergic agent, and the balance being purified water; and the catalyzing gel consists of the following raw materials in percentage by weight: 10 to 80 percent of humectant, 0.5 to 3.0 percent of adhesive, 0.01 to 1 percent of catalyst, 0.1 to 1 percent of preservative, 0.8 to 2 percent of essence, and the balance being purified water. During the use, the whitening gel and the catalyzing gel are mixed evenly according to the proportion of 4: 1, and are directly coated on the surfaces of the teeth. The gel for the bleaching and whitening the teeth has the characteristics of obvious bleaching effect, stability, and durability, can effectively reduce allergic symptoms of the teeth during the whitening treatment, and is suitable for the whitening treatment of the teeth under various conditions.

The present invention relates to a nasal spray containing sodium pyruvate and a preparation method thereof, belonging to the field of medical technology, being characterized in that: the nasal spray containing sodium pyruvate comprises the following components: sodium pyruvate, pyruvic acid, an isoosmotic adjusting agent, a preservative and water. Because the sodium pyruvate is capable of alleviating nasal obstruction and inflammation caused by rhinitis, a medical fluid provided in the invention can be made into a nasal spray medical fluid which is capable of entering nasal cavities by adopting a portable spraying device. The nasal spray medical fluid is particularly suitable for cleaning and removing harmful pollutants in nasal passages, paranasal sinuses and mucosal cilia and is capable of being used in nursing after a nasal cavity operation, relieving rhinostegnosis and reducing respiratory tract irritation and risks of infection. By adding the pyruvic acid to form a buffer solution, tingling caused by using the flushing fluid to wash the cavities can be reduced, and inflammation is alleviated. Allergic symptoms can be prevented or gradually alleviated for the people of special professional who often use the product provided in the invention to wash and care nasal cavities.

Pro-toothpaste compositions formulated to receive a volume of allergen solution to provide toothpastes that exhibit efficacy for oral mucosal immunotherapy (OMIT) and acceptable consumer and product stability properties, along with kits of pro-toothpaste, allergen/extracts of allergens, and optionally compounding means and/or specialized toothbrushes are provided. Toothpastes suitable and effective for OMIT and methods for managing allergic symptoms and for reducing risk of allergy in people without symptoms employing the pro-toothpastes, toothpastes and kits of the invention are also disclosed.

The present invention discloses fermented milk and a preparation method thereof. Raw materials of the fermented milk include the following components: 8.0%-18.0% of original mango juice, 0.006%-7.5% of sweeteners and 0.001%-0.006% of starter culture with raw milk up to 100%, and the percentage = the mass of each component/the total mass of the raw materials. The preparation method comprises the following steps: (1) evenly mixing the raw milk, the sweeteners and the original mango juice to obtain mixture liquid A; (2) homogenizing, sterilizing and cooling the mixture liquid A to obtain mixture liquid B; (3) inoculating the starter culture into the mixture liquid B, and evenly mixing and fermenting the mixture to obtain mixture liquid C; and a fermentation end acidity is 65-75 DEG T; and (4) cooling and after-ripening the mixture liquid C, thereby obtaining the fermented milk. The original mango juice and the raw milk are fermented together to prepare the fermented milk, and the prepared fermented milk is delicate in texture and rich in mouthfeel; and after fermentation, the mango can play a role in alleviating allergic symptoms for people with allergic constitution.

The invention discloses a production method for L-cysteine, and the method belongs to the field of production of amino acids. According to the method, L-cystine, diluted hydrochloric acid with the concentration of 20%, active carbon and a sodium hydroxide aqueous solution with the concentration of 10% are employed as raw materials for producing L-cysteine. The method possesses the advantages of being simple in production technology, mild in reaction conditions, high in substrate conversion rate, free of polluted waste discharge, high in product purity, convenient for batch production, and the like. The main purposes of the product comprise: on the medicine aspect, the product is capable of detoxifying, is capable of effectively preventing and treating radioactive damage, and possesses effects of improving inflammation and skin allergic symptoms; on the cosmetics aspect, the product is a natural whitening cosmetic, and can be used to produce hair-waving essence and sunscreen cream; and on the foodstuff aspect, the product can be used as a bread fermentation promoter, an antistaling agent, a nutrition additive of pet/beast food, and the like.

The object of the present invention is to provide an allergen-reduced royal jelly, having less fear of causing allergic symptoms, obtained by reducing allergens and keeping the useful pharmacological actions of royal jelly, a process for producing the same, and its uses. The present invention solves the above object by providing an allergen-reduced royal jelly where the amount of water-soluble proteins is reduced to less than 50% (w/w) to the amount of total proteins; a process for producing the allergen-reduced royal jelly comprising the steps of separating a royal jelly into a precipitate and a supernatant comprising water-soluble proteins by adding water and centrifuging, collecting low molecular substances by eliminating high molecular substances comprising water-soluble proteins from the resulting supernatant using ultra-filtration or gel filtration chromatography, and mixing the resulting low molecular substances with the aforesaid precipitate; a composition comprising the allergen-reduced royal jelly; and the uses of the composition for foods, feeds, baits, pet foods, and cosmetics.

The invention comprises a separated microorganism strain, which is named Lactobacillus paracasei BRAP-01 and has an allergic symptom-resistance function. The invention also comprises a composition for resisting allergic symptoms, which comprises an effective quantity of the separated microorganism strain and an excipient. The invention also provides a method for stimulating cells to produce interferon-gamma, which comprises the following steps: providing cells of a mammal; and co-culturing the cells of the mammal and the allergic symptom-resistance microorganism strain subjected to heat treatment.

The invention provides an allergy prevention method or treatment method, diets and oral drugs enabling prevention/treatment of allergic symptoms without trouble such as systemic adverse reaction, immune deficiency and the like caused by transdermal/intravenous administration of TGF-β. The allergy prevention method or treatment method is to orally administer 100 μg/kg or more of transforming growth factor-beta (TGF-β) relative to a weight of an administration target body and thereby selectively suppress Th2 immune response, while with respect to the diets and oral drugs, the content is set to contain an effective amount of transforming growth factor-beta (TGF-β) therein.

The invention discloses a preparation method of cow-goat milk mixed-type infant formula milk powder. The preparation method of the cow-goat milk mixed-type infant formula milk powder comprises the following steps: modifying cow milk casein, and adding goat milk beta-casein and demineralized whey powder in proportion of 40:60 according to the ratio of casein to whey protein in human milk. According to the invention, the protein components and proportion are much approximate to those of breast milk, and the immunity and resistance of infant bodies can be improved obviously; the brain, bone, muscle and fat growth and the integral growth and development of infants can be accelerated; the milk powder is easier to digest and absorb; the stomach discomfort cannot be caused, and infants cannot constipate after having the milk powder; the milk power does not contain allergic foreign proteins, cannot lead to milk product allergic symptoms of diarrhea and the like, and is suitable for infants with any corporeity, especially infants who are weak in stomach and intestine and poor in corporeity.

The invention discloses skin confidante cream and a preparation method thereof. The skin confidante cream is prepared from 3-7% of a rhodiola rosea extract, 3-7% of a buckwheat extract, 3-7% of a dandelion extract, 3-7% of a folium artemisiae argyi, 3-7% of an aloe vera extract and 3-7% of a Matricaria extract. Due to the coordination of various plant extracted components, the good moisturizing and antioxidant effects are achieved, allergic symptoms such as skin swelling, pruritus, aches and the like can be effectively prevented, and skin water can be locked. The emulsion is mild in texture, no burden is caused to skin, the effect is lasting, and plant essence in the components can further constantly supplement skin nutrition, reduce fine lines and whiten skin.

The invention relates to a compound composition containing intal and statins claritin. The compound composition consists of the following components: a) a certain amount of intal; b) a certain amount of one of olopatadine hydrochloride, ioratadine, desloratadine, degreasing ioratadine, desloratadine, rupatadine and betahistine; c) other medicinal excipients. The compound composition can be made into external preparations such as eye drops, nose drops, aerosol, spray, inhalant, gelata, eye ointments, ointments or patch and the like. The compound composition can be used for curing the diseases such as anaphylactic eye diseases, anaphylactic rhinitis, skin urtication, urticaria, allergic asthma and the like, can significantly improve allergic symptoms, and has the characteristics of high efficiency, stability, safety, low adverse reaction rate, convenient use and the like.

The invention provides an antipollution composition. The antipollution composition comprises the following components in parts by weight: 1 to 40 parts of butanediol, 1 to 40 parts of 1,3-propanediol,0.1 to 10 parts of hydrolytic sclerotium gum, 0.02 to 10 parts of sodium hyaluronate, 0.2 to 10 parts of trehalose, 0.1 to 30 parts of panthenol, 0.1 to 3 parts of p-hydroxyacetophenone, 0.01 to 20 parts of beta-glucosan, 0.01 to 5 parts of dipotassium glycyrrhizinate, 0.01 to 20 parts of tremella fuciformis extract, 0.01 to 5 parts of an antipollution agent A, 0.01 to 30 parts of an antipollution agent B, 0.01 to 30 parts of an antioxidant and 0.1 to 3 parts of a chelating agent. By adopting the antipollution composition provided in the invention, the harm of pollutants for the skin can be protected in multiple ways, the antipollution agent A forms a physical barrier film on the skin, the adsorption of the pollutants on the skin can be reduced, the skin can be regenerated, the detoxification capacity can be improved, and the skin allergic symptom can be alleviated.

The invention discloses an antiallergic composition and an application thereof in cosmetics. The antiallergic composition comprises the following components in parts by mass: 20-40 parts of flos lonicerae, 10-18 parts of chamomile, 8-13 parts of anthocyanidin, 5-10 parts of a salicylic acid, 8-6 parts of astragalus membranaceus, 2-5 parts of serine, 1-4 parts of phytantriol, 2-4 parts of corn starch sulfonated succinate, 1-1.8 parts of caprylyl glycine, 0.08-1.46 parts of a nicotinic acid, 0.3-1.2 parts of carboxymethyl cellulose, 1.2-3.5 parts of benzoyl peroxide, 0.5-1.1 parts of isopropyl myristate, 0-1 part of an antioxidant, and 0-3 parts of a preservative. The antiallergic composition is composed of traditional Chinese medicines and western medicines in proportion, so that the antiallergic composition is good in antiallergic effect, and can significantly improve the allergic symptoms of the skin after being applied in cosmetics.

It is to provide a composition derived from lactic acid bacteria having an anti-allergic effect (an effect of suppressing allergic symptoms such as hay fever) synergistically, and a food product, pet food, etc. containing the composition. It is to prepare a composition having an anti-allergic action, containing Lactobacillus crispatus KT-11 strain, KT-23 strain, or KT-25 strain bacterial cells and viable bacteria, dead bacteria, or a processed product of bacterial cells of other lactic acid bacteria belonging to the genus Lactobacillus, genus Bifidobacterium, genus Leuconostoc, genus Enterococcus, genus Pediococcus, etc. at a biomass-converted ratio of 99:1 to 50:50, preferably 99:1 to 75:25.

A once daily formulation containing the combination of a non-sedating or selective antihistamine (Loratadine) with a sedating or non-selective antihistamine (Chlorpheniramine) administered at bed-time has demonstrated greater efficacy in relieving allergic symptoms than Loratadine alone.

The invention discloses recovery essential oil for sensitive skin and a preparation method of same. The recovery essential oil is prepared from, by mass, 50-65% of macadimia nut oil, 15-20% of squalane, 2-5% of phytosterol, 2-6% of wheat germ oil, 5-10% of chamomile essential oil, 2-5% of helichrysum italicum essential oil, 1-2% of rosemary leaf oil, 0.2-0.5% of opopanax oil, 1-2% of vitamin E, and 0.2-0.5% of blue chamomile. All the essential oil components in the invention are pure plant-sourced products, so that the recovery essential oil is safe and green and has good permeability, can moisten skin, effectively alleviates various discomforts due to sensitive skin and reduces skin allergic symptoms, such as red rash on facial skin, itching, stabbing pain, dull skin and the like. The essential oil has the refreshing smell of blue chamomile and can heal skin from interior to exterior.

The invention provides a coding gene of scylla paramamosain allergenic protein and an application thereof. The coding gene of the allergenic protein is composed of a nucleotide sequence shown in SEQ ID NO: 1. The invention also discloses an expression vector and a recombinant strain containing the gene, a method for preparing the allergenic protein and the application of the allergenic protein. The coding gene of the scylla paramamosain allergenic protein is cloned into a prokaryotic expression vector, recombinant expression plasmid is constructed, and transferred into host bacteria and inducing expression is carried out; the scylla paramamosain allergenic protein rScy p 9 can be obtained, the IgE binding capacity of the scylla paramamosain allergenic protein rScy p 9 and serum of a crustacean allergic patient is measured, a reference basis can be provided for clinical diagnosis of allergic symptoms and detailed screening of allergens, and prevention, control and treatment of allergicdiseases of the Scy p 9 are timely and accurate.

This invention is to provide an agent for therapy and prevention of allergic diseases which has no adverse action, shows a high safety even by administration for a long period and is able to be utilized to food and/or beverage, cosmetics, etc. which are used daily. To be specific, it provides antiallergic agent and anti-inflammatory agent characterized in containing at least one polyphenol selected from strictinin and methylated derivatives thereof as an effective ingredient; a method for the addition of an antiallergic agent for oral administration or an anti-inflammatory agent for oral administration which is characterized in containing at least one polyphenol selected from strictinin and methylated derivatives thereof as an effective ingredient to food and/or beverage for prevention, suppression and mitigation of allergic symptoms or inflammatory symptoms.

The invention discloses dog-days paste for preventing and treating asthma and a preparation method of the dog-days paste. The dog-days paste is prepared from roasted white mustard seeds, rhizoma corydalis, kansui euphorbia roots and asarum, and the mass ratio of the roasted white mustard seeds, the rhizoma corydalis, the kansui euphorbia roots to the asarum is 6:7:3:4. According to the preparation method, the processing method of the roasted white mustard seeds includes the steps: heating an iron pan for 2 minutes by strong fire, adding raw white mustard seeds, continuing heating by the strong fire and stir-frying the raw white mustard seeds for 5 minutes; regulating the strong fire into soft fire, frying the seeds for 12 minutes and turning off the fire; continuing stir-frying for 15 minutes by waste heat of the iron pan, and discharging the seeds when the raw white mustard seeds turn into deep yellow and slightly emit fragrance to obtain the roasted white mustard seeds. The dog-days paste for preventing and treating the asthma can effectively reduce the occurrence rate of allergic symptoms such as skin foaming.

The invention provides a clinical nutritional formula special for protein allergy. The nutritional formula special for protein allergy is prepared from the following components, by weight, 15-21 partsof protein and amino acids, 11-15 parts of fat, 52-57 parts of carbohydrates, 3.4-4.2 parts of dietary fiber, 1.2-1.8 parts of macroelements, 0.01-0.04 parts of microelements, 0.005-0.02 parts of fat-soluble vitamins, 0.1-0.3 parts of water-soluble vitamin, 0.005-0.11 parts of nucleotides, and 0.02-0.06 parts of natural plant compounds; the invention also provides a method for preparing the aboveclinical nutrition formula. The clinical nutrition formula has the advantage of improving the patient's body mass, enhancing immune function, relieving allergic symptoms and preventing allergic reactions of people with food protein allergies.

The present invention relates to fusion proteins comprising different allergens of the ns-LTPs family, and their use in the prevention and the treatment of allergic symptoms associated to said allergens. In particular, fusion proteins in the form of heterodimers comprising the major allergens of Parietaria judaica, Parj 1 and Parj 2, are described. Methods of preparation of the fusion proteins by expression in genetically modified host cells and pharmaceutical compositions comprising said fusion proteins are described as well.

The invention relates to an essential oil composition for treating rhinitis and a preparation method thereof. The essential oil composition for treating rhinitis comprises the following raw materialsin parts by weight: 56-70 parts of coconut oil, 18-25 parts of beeswax, 4.5-6 parts of candelilla wax, 1.5-2.5 parts of rosemary essential oil, 1.5-2.5 parts of basil essential oil, 1.5-2.5 parts of eucalyptus essential oil, 1.5-2.5 parts of tea tree essential oil, 1.5-2.5 parts of mint essential oil, 0.4-0.6 part of blue tansy essential oil and 0.4-0.6 part of melissa essential oil. The essentialoil composition for treating rhinitis is extracted from plants, has no toxic or side effect, is targeted to rhinitis, can be used for full sterilization and bacteriostasis, can relieve pain and promote tissue regeneration, can relieve and repair nasal mucosa congestion, can improve symptoms such as nasal itching, sneezing, clear water-like nasal discharge and the like, can fully relieve allergicsymptoms, and has an anti-allergic effect. According to the preparation method, the raw materials are only required to be uniformly mixed, the method is simple, the process is easy to control, and large-scale production can be realized.